Success and unsolved issues of embolization of the uterine arteries in uterine fibroid

Abstract

Introduction: According to the clinical recommendations of the Healthcare Ministry of Russia (2021), uterine artery embolization (UAE) in uterine fibroid is an alternative to surgical treatment in case of high surgical risk and absence of contraindications in women who do not desire pregnancy. The advantages of UAE are associated with lesser blood loss, shorter hospital stay, and recovery of the working capacity. Here, we present an analysis of the literature and our 14-year clinical experience in performing UAE in uterine fibroid. Screening and primary diagnosis of uterine fibroid and indications and contraindications of UAE in the current publications were analyzed. Different methods of EUA implementation were described, and the advantages of the transradial access (TRA) are demonstrated on the basis of the actual clinical experience.

Conclusion: The results obtained in the use of TRA revealed the reduction of radioscopy time and surgery time in general, which are beneficial in terms of the reduction of radiation exposure. Besides, an argument for the given access is a considerably lower frequency of serious complications at the access site. The main obstacles to the introduction and wide use of TRA are based on the lack of specialist experience, absence of specialized training programs, and use of unsuitable and traumatizing instruments. One of the unsolved questions is the absence of an anesthesia protocol, which must be developed with the participation of both gynecologists and specialists on X-ray endovascular diagnostics and treatment.

Keywords

uterine fibroid / uterine artery embolization / transradial access / radial access

References

[1] Klinicheskiye rekomendatsii Ministerstva zdravookhraneniya Rossiyskoy Federatsii. Mioma matki. 2020. Available at: http://chelsma.ru/files/misc/kr_miomamatki.pdf. Accessed:

[2] Клинические рекомендации МЗ РФ. Миома матки. 2020. Доступно по: http://chelsma.ru/files/misc/kr_miomamatki.pdf. Ссылка активна

[3] Mas A, Tarazona M, Carrasco JD, et al. Updated approaches for management of uterine fibroids. International Journal of Women’s Health. 2017;9:607–17. doi: 10.2147/IJWH.S138982

[4] Mas A., Tarazona M., Carrasco J.D., et al. Updated approaches for management of uterine fibroids // International Journal of Women’s Health. 2017. Vol. 9. P. 607–617. doi: 10.2147/IJWH.S138982

[5] Czuczwar P, Stepniak A, Milart P, et al. Comparison of the influence of three fibroid treatment options: Supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve — an observational study. Journal of Ovarian Research. 2018;11(1):45. doi: 10.1186/s13048-018-0420-1

[6] Czuczwar P., Stepniak A., Milart P., et al. Comparison of the influence of three fibroid treatment options: Supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve — an observational study // Journal of Ovarian Research. 2018. Vol. 11, № 1. P. 45. doi: 10.1186/s13048-018-0420-1

[7] Khamadyanov UR, Kulesсhova TP, Sibayeva ML, et al. Modern possibilities of diagnostics and treatment of uterine myomas. Bashkortostan Medical Journal. 2010;(4):40–4.

[8] Хамадьянов У.Р., Кулешова Т.П., Сибаева М.Л., и др. Современные возможности диагностики и лечения миом матки // Медицинский вестник Башкортостана. 2010. № 4. С. 40-44.

[9] Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolization to treat uterine myomata. Lancet. 1995;346(8976):671–2. doi: 10.1016/s0140-6736(95)92282-2

[10] Ravina J.H., Herbreteau D., Ciraru-Vigneron N., et al. Arterial embolization to treat uterine myomata // Lancet. 1995. Vol. 346, № 8976. P. 671–672. doi: 10.1016/s0140-6736(95)92282-2

[11] Edwards RD, Moos JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. The New England Journal of Medicine. 2007;356(4):360–70. doi: 10.1056/NEJMoa062003

[12] Edwards R.D., Moos J.G., Lumsden M.A., et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids // The New England Journal of Medicine. 2007. Vol. 356, № 4. P. 360–370. doi: 10.1056/NEJMoa062003

[13] HehenkampWJK, Volkers NA, Birnie E, et al. Symptomatic uterine fibroids: treatment with uterineartery embolization or hysterectomy. Results from the randomized clinical embolization versus hysterectomy (EMMY) trial 1. Radiology. 2008;246(3):823–32. doi: 10.1148/radiol.2463070260

[14] HehenkampW.J.K., Volkers N.A., Birnie E., et al. Symptomatic uterine fibroids: treatment with uterineartery embolization or hysterectomy. Results from the randomized clinical embolization versus hysterectomy (EMMY) trial 1 // Radiology. 2008. Vol. 246, № 3. P. 823–832. doi: 10.1148/radiol.2463070260

[15] Alekyan BG, Pokrovskiy АV, Karapetyan NG, et al. Hospital results of endovascular treatment for combined lesions of intermittent claudication and coronary artery disease. Russian Journal of Endovascular Surgery. 2020;7(2):130–7 (In Russ). doi: 10.24183/2409-4080-2020-7-2-130-137

[16] Алекян Б.Г., Покровский А.В., Карапетян Н.Г., и др. Госпитальные РЕЗУЛЬТАТЫ рентгенэндоваскулярного лечения пациентов с хронической ишемией нижних конечностей в сочетании с ишемической болезнью сердца // Эндоваскулярная хирургия (специальный выпуск). 2020. Т. 7, № 2. С. 130–137. doi: 10.24183/2409-4080-2020-7-2-130-137

[17] Yang T, Pandya A, Marcal L, et al. Sonohysterography: Principles, technique and role in diagnosis of endometrial pathology. World Journal of Radiology. 2013;5(3):81–7. doi: 10.4329/wjr.v5.i3.81

[18] Yang T., Pandya A., Marcal L., et al. Sonohysterography: Principles, technique and role in diagnosis of endometrial pathology // World Journal of Radiology. 2013. Vol. 5, № 3. P. 81–87. doi: 10.4329/wjr.v5.i3.81

[19] Kirby JM, Burrows D, Haider E, et al. Utility of MRI before and after uterine artery embolization: why to do it and what to look for. Cardiovascular and Interventional Radiology. 2011;34(4):705–16. doi: 10.1007/s00270-010-0029-2

[20] Kirby J.M., Burrows D., Haider E., et al. Utility of MRI before and after uterine artery embolization: why to do it and what to look for // Cardiovascular and Interventional Radiology. 2011. Vol. 34, № 4. P. 705–716. doi: 10.1007/s00270-010-0029-2

[21] McLucas B, Goodwin S, Adler L, et al. Pregnancy following uterine fibroid embolization. International Journal of Gynaecology and Obstetrics. 2001;74(1):1–7. doi: 10.1016/s0020-7292(01)00405-2

[22] McLucas B., Goodwin S., Adler L., et al. Pregnancy following uterine fibroid embolization // International Journal of Gynaecology and Obstetrics. 2001. Vol. 74, № 1. P. 1–7. doi: 10.1016/s0020-7292(01)00405-2

[23] Рarthipun AA, Taylor J, Manyonda I, et al. Does sizereally matter? Analysis of the effect of large fibroids and uterinevolumes on complication rates of uterine artery embolization. Cardiovascular and Interventional Radiology. 2010;33(5):955–9. doi: 10.1007/s00270-010-9842-x

[24] Рarthipun A.A., Taylor J., Manyonda I., et al. Does sizereally matter? Analysis of the effect of large fibroids and uterinevolumes on complication rates of uterine artery embolization // Cardiovascular and Interventional Radiology. 2010. Vol. 33, № 5. P. 955–959. doi: 10.1007/s00270-010-9842-x

[25] Smeets AJ, Nijenhuis RJ, van Rooij WJ, et al Uterine artery embolization in patients with a large fibroid burden: long-term clinical and MR follow-up. Cardiovascular and Interventional Radiology. 2010;33(5):943–8. doi: 10.1007/s00270-009-9793-2

[26] Smeets A.J., Nijenhuis R.J., van Rooij W.J., et al Uterine artery embolization in patients with a large fibroid burden: long-term clinical and MR follow-up// Cardiovascular and Interventional Radiology. 2010. Vol. 33, № 5. P. 943–948. doi: 10.1007/s00270-009-9793-2

[27] Sharafutdinov BM, Antropova EYu, Ryzhkin SA, et al. Endovascular Embolization of the Uterine Arteries in Giant Uterine Fibroids. Journal of Radiology and Nuclear Medicine. 2021;102(3):172–7. (In Russ). doi: 10.20862/0042-4676-2021-102-3-172-177

[28] Шарафутдинов Б.М., Антропова Е.Ю., Рыжкин С.А., и др. Рентгенэндоваскулярная эмболизация маточных артерий при гигантских миомах матки // Вестник рентгенологии и радиологии. 2021. Т. 102, № 3. С. 172–177. doi: 10.20862/0042-4676-2021-102-3-172-177

[29] Smeets AJ, Nijenhuis RJ, Boekkooi PF, et al. Is an intrauterine device a contraindication for uterine artery embolization? A study of 20 patients. Journal of Vascular and Interventional Radiology. 2010;21(2):272–4. doi: 10.1016/j.jvir.2009.10.016

[30] Smeets A.J., Nijenhuis R.J., Boekkooi P.F., et al. Is an intrauterine device a contraindication for uterine artery embolization? A study of 20 patients // Journal of Vascular and Interventional Radiology. 2010. Vol. 21, № 2. P. 272–274. doi: 10.1016/j.jvir.2009.10.016

[31] De Blok S, de Vries C, Prinssen HM, et al. Fatal sepsis after uterine artery embolization with microspheres. Journal of Vascular and Interventional Radiology. 2003;14(6):779–83. doi: 10.1097/01.rvi.0000079988.80153.61

[32] De Blok S., de Vries C., Prinssen H.M., et al. Fatal sepsis after uterine artery embolization with microspheres // Journal of Vascular and Interventional Radiology. 2003. Vol. 14, № 6. P. 779–783. doi: 10.1097/01.rvi.0000079988.80153.61

[33] Sharafutdinov BM. Optimizatsiya rentgen·endovaskulyarnoy embolizatsii matochnykh arteriy pri lechenii bol’nykh s miomami matki i matochnymi krovotecheniyami [dissertation]. Kazan’; 2015. (In Russ).

[34] Шарафутдинов Б.М. Оптимизация рентгенэндоваскулярной эмболизации маточных артерий при лечении больных с миомами матки и маточными кровотечениями: автореферат дис. ... канд. мед. наук. Казань; 2015.

[35] Neill J, Douglas H, Richardson G, et al. Comparison of radiation dose and the effect of operator experience in femoral and radial arterial access for coronary procedures. The American Journal of Cardiology. 2010;106(7):936–40. doi: 10.1016/j.amjcard.2010.06.002

[36] Neill J., Douglas H., Richardson G., et al. Comparison of radiation dose and the effect of operator experience in femoral and radial arterial access for coronary procedures // The American Journal of Cardiology. 2010. Vol. 106, № 7. P. 936–940. doi: 10.1016/j.amjcard.2010.06.002

[37] Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. American Heart Journal. 2009;157(1):132–40. doi: 10.1016/j.ahj.2008.08.023

[38] Jolly S.S., Amlani S., Hamon M., et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials // American Heart Journal. 2009. Vol. 157, № 1. P. 132–140. doi: 10.1016/j.ahj.2008.08.023

[39] Carnpeau L. Percutaneous Radial Artery Approach for Coronary Angiography. Catheterization and Cardiovascular Diagnosis. 1989;16(1):3–7. doi: 10.1002/ccd.1810160103

[40] Carnpeau L. Percutaneous Radial Artery Approach for Coronary Angiography // Catheterization and Cardiovascular Diagnosis. 1989. Vol. 16, № 1. P. 3–7. doi: 10.1002/ccd.1810160103

[41] Sharafutdinov BM, Antropova EYu, Ryzhkin SA, et al. Impact of radiation exposure on ovarian reserve after uterine artery embolization. Vopr. ginekol. akus. perinatol. Gynecology, Obstetrics and Perinatology. 2020;19(3):22–9. (In Russ). doi: 10.20953/1726-1678-2020-3-22-29

[42] Шарафутдинов Б.М., Антропова Е.Ю., Рыжкин С.А. Влияние лучевой нагрузки на овариальный резерв яичников после эмболизации маточных артерий // Вопросы гинекологии, акушерства и перинатологии. 2020. Т. 19, № 3. С. 22–29. doi: 10.20953/1726-1678-2020-3-22-29

[43] Antropova EYu, Korobov VV. Otsenka post·embolizatsionnogo sindroma u patsiyentok s miomoy matki. Medical Almanac. 2011;(6):134–7. (In Russ).

[44] Антропова Е.Ю., Коробов В.В. Оценка постэмболизационного синдрома у пациенток с миомой матки // Медицинский альманах. 2011. № 6 (19). С. 134–137.

[45] Zeliuk SV, Mirovich ED. The function of ovaries after hysterectomy. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2012;15(2, Pt 1):132–5. (In Russ).

[46] Зелюк С.В., Мирович Е.Д. Функция яичников после гистерэктомии // Таврический медико-биологический вестник. 2012. Т. 15, № 2, ч. 1 (58). С. 132–135.

[47] Gevorkyan MA, Fataliyeva KZ. Rol’ gormonoterapii v profilaktike menopauzal’nogo metabolicheskogo sindroma. Obstetrics, Gynecology and Reproduction. 2009;(6):4–9. (In Russ).

[48] Геворкян М.А., Фаталиева К.З. Роль гормонотерапии в профилактике менопаузального метаболического синдрома // Акушерство. Гинекология. Репродукция. 2009. № 6. С. 4–9.

[49] Kristić I, Lukenda J. Radial artery spasm during transradial coronary procedures. The Journal of Invasive Cardiology. 2011;23(12):527–31.

[50] Kristić I., Lukenda J. Radial artery spasm during transradial coronary procedures // The Journal of Invasive Cardiology. 2011. Vol. 23, № 12. P. 527–531.

[51] Tikhomirov AL, Dedy TV, Sarsania SI, et al. Latest strategy the management of patients with uterine fibroids in the outpatient setting. Difficult Patient. 2021;19(4):12–7. (In Russ). doi: 10.224412/2074-1005-2021-4-12-17

[52] Тихомиров А.Л., Деды Т.В., Сарсания С.И., и др. Актуальная стратегия ведения пациенток с миомой матки в амбулаторных условиях // Трудный пациент. 2021. Т. 19, № 4. С. 12–17. doi: 10.224412/2074-1005-2021-4-12-17